Selective phosphodiesterase 4B inhibition in fibrotic lung disease: a scoping review of vascular–immune mechanisms and extrapulmonary implications
- DOI
- 10.1183/16000617.0095-2026
- Published
- 2026-07
- Container
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1183/16000617.0095-2026,
title = {Selective phosphodiesterase 4B inhibition in fibrotic lung disease: a scoping review of vascular–immune mechanisms and extrapulmonary implications},
author = {Fabio Perrotta and Domenica Francesca Mariniello and Raffaella Pagliaro and Andrea Bianco},
year = {2026},
journal = {European Respiratory Review},
doi = {10.1183/16000617.0095-2026},
url = {https://doi.org/10.1183/16000617.0095-2026}
}RIS
TY - JOUR TI - Selective phosphodiesterase 4B inhibition in fibrotic lung disease: a scoping review of vascular–immune mechanisms and extrapulmonary implications AU - Fabio Perrotta AU - Domenica Francesca Mariniello AU - Raffaella Pagliaro AU - Andrea Bianco PY - 2026 JO - European Respiratory Review DO - 10.1183/16000617.0095-2026 UR - https://doi.org/10.1183/16000617.0095-2026 ER -
APA
Perrotta, F., Mariniello, D. F., Pagliaro, R., & Bianco, A. (2026). Selective phosphodiesterase 4B inhibition in fibrotic lung disease: a scoping review of vascular–immune mechanisms and extrapulmonary implications. European Respiratory Review. https://doi.org/10.1183/16000617.0095-2026
Source records
- crossref · retrieved 2026-09-27T02:19:59.946Z